Article Information
History
- March 11, 2024.
Article Versions
- Version 1 (January 20, 2024 - 07:18).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- M Vera-Aviles1,*,
- S Kabir1,*,
- A Shah2,*,
- P Polzella3,*,
- Y Lim1,
- P Buckley1,
- C Ball1,
- D Swinkels4,
- H Matlung5,
- C Blans5,
- P Holdship6,
- J Nugent7,
- E Andreson7,
- M Desborough3,
- S Piechnik8,
- V Ferreira8 and
- S Lakhal-Littleton1,#
- 1Department of Physiology, Anatomy & Genetics, University of Oxford
- 2Nuffield Department of Clinical Neurosciences, University of Oxford
- 3Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust
- 4Iron Expertise Centre, Department of Laboratory Medicine, Radboud university medical centre, Nijmegen, Netherlands & Iron Expertise Centre, Sanquin Blood Bank, Amsterdam, Netherlands
- 5Sanquin Diagnostic Services, Amsterdam, Netherlands & Sanquin Research and Landsteiner Laboratory, Amsterdam, Netherlands
- 6Department of Earth Sciences, University of Oxford
- 7Department of Chemistry, University of Oxford
- 8Oxford Centre for Clinical Magnetic Resonance Research (OCMR), University of Oxford
- ↵#Correspondence: Prof S Lakhal-Littleton, Department of Physiology, Anatomy & Genetics, Sherrington Building, Parks Road, Oxford, OX1 3PT samira.lakhal-littleton{at}dpag.ox.ac.uk
↵* Equal contribution
Posted March 11, 2024.
Intravenous iron therapy with ferric carboxymaltose results in a rapid and sustained rise in myocardial iron content through a non-canonical pathway: a translational study
